4.7 Review

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus

Journal

STEM CELLS
Volume 29, Issue 1, Pages 5-10

Publisher

WILEY-BLACKWELL
DOI: 10.1002/stem.556

Keywords

Mesenchymal stem cell; Cardiomyopathy; Nephropathy; Neuropathy; Wound; Diabetes mellitus

Ask authors/readers for more resources

Mesenchymal stem cells (MSCs) are multipotent, self-renewing cells that can be found in almost all postnatal organs and tissues. The main functional characteristics of MSCs are their immunomodulatory ability, capacity for self-renewal, and differentiation into mesodermal tissues. The ability of MSCs to differentiate into several cell types, including muscle, brain, vascular, skin, cartilage, and bone cells, makes them attractive as therapeutic agents for a number of diseases including complications of diabetes mellitus. We review here the potential of MSCs as new therapeutic agents in the treatment of diabetic cardiomyopathy, diabetic nephropathy, diabetic polyneuropathy, diabetic retinopathy, and diabetic wounds. Also, in this review we discuss the current limitations for MSCs therapy in humans. STEM CELLS 2011;29:5-10

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available